Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors

  • Meric-Bernstam F
  • Arkenau H
  • Tran B
  • et al.
N/ACitations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Surface electromyography (sEMG) is extensively investigated in human-computer interface (HCI) for prostheses control to improve the the life quality of the amputees. Near-infrared spectroscopy (NIRS) reflecting muscle activity in hemo-dynamics and metabolism, is less explored in HCI applications. Reasonably combining the advantages of both sEMG and NIRS would provide a novel approach to enhance the sEMG based HCI performance. This paper presents an enhanced HCI via decoding sEMG and NIRS simultaneously. Pattern recognition experiment of thirteen motion classes is performed with seven feature sets extracted and compared. The results show that the classification accuracy is significantly (P

Cite

CITATION STYLE

APA

Meric-Bernstam, F., Arkenau, H., Tran, B., Bahleda, R., Kelley, R., Hierro, C., … Goyal, L. (2018). Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors. Annals of Oncology, 29, v100. https://doi.org/10.1093/annonc/mdy149

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free